Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 225-757-8354
Dr. Cataldo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
Louisiana State University School of MedicineResidency, Internal Medicine, 2002 - 2005- Louisiana State University School of Medicine in New OrleansClass of 2002
Certifications & Licensure
TX State Medical License 2006 - 2026
LA State Medical License 2003 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC) Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 18 citationsNeutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.Wesley H Self, Allison P Wheeler, Thomas G Stewart, Harry Schrager, Jason Mallada
Chest. 2022-11-01 - 5 citationsLong-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.Darla K. Liles, Nirmish Shah, Brigid Scullin, Victor R. Gordeuk, Wally R. Smith
British Journal of Haematology. 2021-10-05 - 21 citationsEfficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma.Andrew James Wiele, Devaki Shilpa Surasi, Priya Rao, Kanishka Sircar, Xiaoping Su
Cancers. 2021-04-30
Press Mentions
Mary Bird Perkins Launches Helping Hands Online Registry for Cancer PatientsSeptember 9th, 2020- OLOL Seeing 'Severe Shortage' in Recovered COVID-19 Convalescent Plasma DonationsJuly 9th, 2020
Healthline: ImmunotherapyDecember 23rd, 2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
